Talazoparib (Tala) in patients (pts) with solid tumors with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. Temsirolimus (T) in patients (pts) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results